Pyrimidine derivatives for the treatment of abnormal cell growth

Details for Australian Patent Application No. 2005243397 (hide)

Owner Pfizer Products Inc.

Inventors Kath, John Charles; Luzzio, Michael Joseph

Agent Spruson & Ferguson

Pub. Number AU-A-2005243397

PCT Pub. Number WO2005/111023

Priority 60/571,312 14.05.04 US

Filing date 2 May 2005

Wipo publication date 24 November 2005

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/111023 Priority application(s): WO2005/111023

10 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243401-Suspension plate for fixing to ceiling

2005243384-Thiazole compound and use thereof